These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 10070170

  • 1. ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy.
    Remuzzi A, Perico N, Sangalli F, Vendramin G, Moriggi M, Ruggenenti P, Remuzzi G.
    Am J Physiol; 1999 Mar; 276(3):F457-66. PubMed ID: 10070170
    [Abstract] [Full Text] [Related]

  • 2. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.
    Perico N, Remuzzi A, Sangalli F, Azzollini N, Mister M, Ruggenenti P, Remuzzi G.
    J Am Soc Nephrol; 1998 Dec; 9(12):2308-17. PubMed ID: 9848785
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy.
    Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G.
    Kidney Int; 1991 Jun; 39(6):1267-73. PubMed ID: 1716713
    [Abstract] [Full Text] [Related]

  • 4. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
    Pechère-Bertschi A, Nussberger J, Decosterd L, Armagnac C, Sissmann J, Bouroudian M, Brunner HR, Burnier M.
    J Hypertens; 1998 Mar; 16(3):385-93. PubMed ID: 9557932
    [Abstract] [Full Text] [Related]

  • 5. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators.
    Larochelle P, Flack JM, Marbury TC, Sareli P, Krieger EM, Reeves RA.
    Am J Cardiol; 1997 Dec 15; 80(12):1613-5. PubMed ID: 9416950
    [Abstract] [Full Text] [Related]

  • 6. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
    Ruggenenti P, Mosconi L, Sangalli F, Casiraghi F, Gambara V, Remuzzi G, Remuzzi A.
    Kidney Int; 1999 Mar 15; 55(3):984-94. PubMed ID: 10027935
    [Abstract] [Full Text] [Related]

  • 7. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
    Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM.
    Am J Kidney Dis; 2001 Jul 15; 38(1):18-25. PubMed ID: 11431176
    [Abstract] [Full Text] [Related]

  • 8. Influence of irbesartan and enalapril on changes of renal function associated with the established phase of l-NAME hypertension.
    Jover B, Herizi A, Casellas D, Mimran A.
    J Hypertens; 2001 Nov 15; 19(11):2039-46. PubMed ID: 11677370
    [Abstract] [Full Text] [Related]

  • 9. Effects of angiotensin II receptor blockade on remnant glomerular permselectivity.
    Mayer G, Lafayette RA, Oliver J, Deen WM, Myers BD, Meyer TW.
    Kidney Int; 1993 Feb 15; 43(2):346-53. PubMed ID: 7680077
    [Abstract] [Full Text] [Related]

  • 10. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.
    Liu E, Xu Z, Li J, Yang S, Yang W, Li G.
    Int J Cardiol; 2011 Feb 03; 146(3):364-70. PubMed ID: 19732978
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome.
    Remuzzi A, Schieppati A, Battaglia C, Remuzzi G.
    Am J Kidney Dis; 1989 Sep 03; 14(3):170-7. PubMed ID: 2476029
    [Abstract] [Full Text] [Related]

  • 12. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G.
    Am J Kidney Dis; 2000 Mar 03; 35(3):381-91. PubMed ID: 10692263
    [Abstract] [Full Text] [Related]

  • 13. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.
    Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H.
    Am J Nephrol; 2000 Mar 03; 20(5):373-9. PubMed ID: 11092994
    [Abstract] [Full Text] [Related]

  • 14. Acute renal effects of AT1-receptor blockade after exogenous angiotensin II infusion in healthy subjects.
    Schmitt F, Martinez F, Brillet G, Nguyen-Khoa T, Brouard R, Sissmann J, Lacour B, Grunfeld JP.
    J Cardiovasc Pharmacol; 1998 Feb 03; 31(2):314-21. PubMed ID: 9475275
    [Abstract] [Full Text] [Related]

  • 15. Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade.
    Ferrari P, Marti HP, Pfister M, Frey FJ.
    J Hypertens; 2002 Jan 03; 20(1):125-30. PubMed ID: 11791035
    [Abstract] [Full Text] [Related]

  • 16. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.
    Presse Med; 2002 Nov 09; 31(36):1714-20. PubMed ID: 12467154
    [Abstract] [Full Text] [Related]

  • 17. Randomized, double-blind comparison of irbesartan and enalapril for treatment of mild to moderate hypertension.
    Chiou KR, Chen CH, Ding PY, Chen YT, Ting CT, Huang JL, Chiang AH, Liu CP, Tseng CJ, Chao CT, Chang MS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May 09; 63(5):368-76. PubMed ID: 10862446
    [Abstract] [Full Text] [Related]

  • 18. ACE inhibitors and angiotensin II receptor blockers in IgA nephropathy with mild proteinuria: the ACEARB study.
    Pozzi C, Del Vecchio L, Casartelli D, Pozzoni P, Andrulli S, Amore A, Peruzzi L, Coppo R, Locatelli F, Adulto e Bambino Study Group, Immunopatologia Renale Study Group of the Italian Society of Nephrology.
    J Nephrol; 2006 May 09; 19(4):508-14. PubMed ID: 17048209
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G.
    J Clin Invest; 1990 Feb 09; 85(2):541-9. PubMed ID: 1688888
    [Abstract] [Full Text] [Related]

  • 20. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial.
    Fernandez Juarez G, Luño J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, Cachofeiro V, Nieto J, Fernández Vega F, Tato A, Gutierrez E, PRONEDI Study Group.
    Am J Kidney Dis; 2013 Feb 09; 61(2):211-8. PubMed ID: 22939518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.